New study explores whether dampening IL-6 could address serious coronavirus infections

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations

Amid university shutdowns worldwide, professors and students adjust what social distancing means for lab scientists

Posters and presentations can be uploaded to SciMeetings starting on March 19

Veterans of teaching chemistry online offer advice for professors challenged by the COVID-19 pandemic

WHO does not recommend against taking the drug for fever caused by novel coronavirus infection

Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines

NO₂ levels have fallen sharply in northern Italy and China

Large, disordered pores allow the gel to capture soil without damaging pigments

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2-specific data are lacking

Agency's approach for assessing risks to endangered species relies on real-world data

The first female CEO of a European chemical major begins a financial, social, and environmental overhaul of one of the oldest chemical firms

Strategy reduces volumes and times needed to evaluate CO₂-switchable systems

Companies are making their machines and expertise available to hospitals in need of parts

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for the virus causing COVID-19

Chemistry CROs are back in business as rest of world starts to lock down

Many are FDA-approved drugs that could be repurposed

Nearly perfect, long-lasting crystalline catalyst turns CO₂ into valuable products

Italian workers threaten to strike, but German, UK companies and workers pull together

Long-awaited image of elusive disordered tail helps scientists better understand the enzyme's mechanism

Old anti-malarial drugs have shown mixed results in the small clinical trials conducted so far

E-cigarettes deliver lead, arsenic, nickel, and other metals at harmful levels

The nucleoside inhibitor has advantages over Gilead's remdesivir but has yet to be tested in humans

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations

Companies are making their machines and expertise available to hospitals in need of parts

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for COVID-19

Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts

The National Institutes of Health receives the vast majority of the support

Technology could lessen the environmental impact of 3-D printed buildings by adapting locally harvested soils

Activists say broad lack of enforcement threatens safety

Lingering logistic problems and a sputtering economy mean hard times for companies

With a diagnostic backlog hampering disease control efforts, scientists are turning to CRISPR and other technologies to bridge the gap

System combines compounds in unfamiliar ways

Using lasers to directly create graphene on Kevlar makes it easy to integrate electronics on textiles

Auto manufacturing is the first sector to halt demand for chemicals

These biomolecules could hold clues to why the virus is so infectious and to how to stop it